ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

OKYO Okyo Pharma Limited

91.00
0.00 (0.00%)
Last Updated: 00:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Okyo Pharma Limited LSE:OKYO London Ordinary Share GG00BD3FV870 ORD NPV
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 91.00 1.20 1.60 0.00 00:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

OKYO Pharma Limited Change of Delisting Date to 22 May 2023 (0191Z)

11/05/2023 7:00am

UK Regulatory


Okyo Pharma (LSE:OKYO)
Historical Stock Chart


From Mar 2023 to Mar 2024

Click Here for more Okyo Pharma Charts.

TIDMOKYO

RNS Number : 0191Z

OKYO Pharma Limited

11 May 2023

11 May 2023

OKYO Pharma Limited

("OKYO" or "Company")

Change of Delisting Date to 22 May 2023

The board of directors of OKYO Pharma Limited (LSE: OKYO; NASDAQ: OKYO), announces that it has delayed the date on which the cancellation of its ordinary shares of no par value each ("Ordinary Shares") from listing on the standard segment of the FCA's Official List and trading on the main market for listed securities of the LSE ("Main Market") ("Delisting") will take place until Monday, 22 May 2023. This is a facilitate late transfers of certificated positions into CREST ahead of the Delisting.

The Delisting will have no impact on the Company's American Depositary Shares ("ADSs") (each currently representing 65 Ordinary Shares) which are traded on Nasdaq.

The securities to which the Delisting relates are the Ordinary Shares of OKYO Pharma Limited with ISIN GG00BD3FV870. Following the Delisting, it will no longer be possible to trade the Ordinary Shares on the Main Market or any other market of the LSE.

Information for holders through CREST

Following the share consolidation (which will take place on the Delisting Date), holders of the Company's ordinary shares in CREST will receive a CDI (a CREST depositary interest issued by Euroclear) into their CREST account, with each CDI representing one new ordinary share. The CDIs can be exchanged for the new ordinary shares within the CREST system. Full instructions will be posted to the Company's website when Delisting has occurred.

Information for holders in certificated form

For persons who currently hold Ordinary Shares in certificated form, these shareholders will receive a "DRS Statement" from the Company's US transfer agent, by post. The DRS Statement will explain how to dematerialise the underlying shares into a trading account. ANY SHAREHOLDERS WHO CURRENTLY HOLD ORDINARY SHARES IN CERTIFICATED FORM ARE URGED TO SPEAK TO THEIR STOCKBROKER OR SHARE DEALING PLATFORM AND TO MOVE THEIR CERTIFICATED ORDINARY SHARES INTO CREST PRIOR TO THE DELISTING DATE. THIS WILL SUBSTANTIALLY SIMPLIFY THE PROCESS FOR RECEIVING NASDAQ TRADED ORDINARY SHARES. ANY HOLDER OF CERTIFICATED ORDINARY SHARES SHOULD ALSO ENSURE THAT THE COMPANY'S REGISTRAR HAS FULLY UP-TO-DATE INFORMATION AS TO THEIR CURRENT ADDRESS AS DRS STATEMENTS CANNOT EASILY BE REISSUED.

Enquiries:

 
                        Gary S. Jacob, Chief 
 OKYO Pharma Limited     Executive Officer      +44 (0)20 7495 2379 
 Investor Relations     Paul Spencer            +44 (0)20 7495 2379 
 Optiva Securities 
  Limited 
  (Broker)              Robert Emmet            +44 (0)20 3981 4173 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

MSCGPUWCAUPWGRU

(END) Dow Jones Newswires

May 11, 2023 02:00 ET (06:00 GMT)

1 Year Okyo Pharma Chart

1 Year Okyo Pharma Chart

1 Month Okyo Pharma Chart

1 Month Okyo Pharma Chart

Your Recent History

Delayed Upgrade Clock